Pharmacology
News
Novel therapy shows promise for treating skin-predominant dermatomyositis
The study drug “is a potent, selective humanized IgG1-neutralizing antibody directed at IFN-beta,” said Dr. Aaron Mangold, the principal...
News
Another FDA class I recall of Cardiosave Hybrid/Rescue IABPs
The coiled cable connecting the display and base on some units may fail, causing an unexpected shutdown, without warnings or alarms to alert the...
News
Novel single-use patch shows promise for primary axillary hyperhidrosis
“This is a new kind of device that is going to be a nice tool to have.”
News
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
The recently approved deucravacitinib is the only JAK inhibitor that has so far been exempt from these warnings.
Conference Coverage
Lanolin gets nod for Allergen of the Year
Controversy continues over lanolin allergenicity; some patients with positive patch tests can tolerate lanolin ingredients.
News
Study finds quality of topical steroid withdrawal videos on YouTube subpar
“We were disheartened that patient testimonial videos had the poorest quality and reliability of the information sources,” Erika McCormick said....
Conference Coverage
Upadacitinib shows positive endoscopic outcomes in Crohn’s disease at 1 year
“The absolute magnitude of the finding was unanticipated – a greater treatment effect than might be anticipated for these outcomes compared with...
Conference Coverage
Oral PCSK9 inhibitor shows encouraging LDL lowering
A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.
News
Spironolactone: an ‘inexpensive, effective’ option for acne in women
“Spironolactone is fairly accessible, inexpensive, and effective for our patients,” Dr. Julie C. Harper said.
News
Lebrikizumab monotherapy for AD found safe, effective during induction